Cas9
Cas9
Merosin-deficient congenital muscle dystrophy type 1a, MDC1a, (NCT06582537)
Sponsors:
Maastricht University
Sponsors:
Maastricht University
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
Liver Transplant, (NCT07053488)
Sponsors:
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
Sponsors:
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
IND Enabling
Phase I
Phase II
Phase III
High-grade Squamous Intraepithelial Lesions, HSIL, (NCT07170254)
Sponsors:
Shanghai BDgene Co., Ltd.
Sponsors:
Shanghai BDgene Co., Ltd.
IND Enabling
Phase I
Phase II
Phase III
End-Stage Renal Disease, (NCT07053462)
Sponsors:
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
Sponsors:
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
IND Enabling
Phase I
Phase II
Phase III
Relapsed or Refractory Acute Myeloid Leukaemia, AML, (NCT07026942)
Sponsors:
Nationwide Children's Hospital
Sponsors:
Nationwide Children's Hospital
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III